Phosphorylated c-Myc expression in Alzheimer disease, pick's disease, progressive supranuclear palsy and corticobasal degeneration

Neuropathology and Applied Neurobiology

Volumn 27, Issue 5, 2001, Pages 343-351

  Ferrer, I ^a   Blancom Carmonab Puig, R ^a,b  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Alzheimer disease; c Myc; Corticobasal degeneration; Mitogen activated protein kinases; Neurofibrillary degeneration; Pick's disease; Progressive supranuclear palsy; Tau

Indexed keywords

CASPASE 3; CELL CYCLE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MYC PROTEIN; NUCLEAR PROTEIN; PROTEIN ANTIBODY; RAS PROTEIN; SERINE; TAU PROTEIN; THREONINE;

ADULT; AGED; ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; BRAIN NERVE CELL; CELL INCLUSION; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; ENZYME ACTIVATION; FEMALE; GLIA CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MEDULLOBLASTOMA; NERVE CELL NECROSIS; NEURITE; NEUROBLASTOMA; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NEUROPATHY; PICK PRESENILE DEMENTIA; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; TUMOR CELL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOPTOSIS; BRAIN DISEASES; CASPASE 3; CASPASES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; NEUROFIBRILLARY TANGLES; PHOSPHORYLATION; PICK DISEASE OF THE BRAIN; PROTO-ONCOGENE PROTEINS C-MYC; SUPRANUCLEAR PALSY, PROGRESSIVE; TAU PROTEINS;

EID: 0034768559     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2990.2001.00348.x     Document Type: Article

References (63)

1. Aberrancies in signal transduction and cell cycle related events in Alzheimer's disease
2. Particular nuclear transcription factors responsive to systemic administration of kainic acid in murine brain
3. Max encodes a sequence-specific DNA-binding protein and is not regulated by serum growth factors
4. Binding of myc proteins to canonical and noncanonical DNA sequences
5. Sequence-specific DNA binding by the c-Myc protein
6. Max: A helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc
7. Myc and Max function as a nucleoprotein complex
8. Myc and Max associate in vivo
9. Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain
10. How MAP kinases are regulated
11. The Myc oncoprotein: A critical evaluation of transactivation and target gene regulation
12. Activation of cell-cycle-associated proteins in neuronal death: A mandatory or dispensable path?
13. Both the helix-loop-helix and the leucine zipper motifs of c-Myc contribute to its dimerization specificity with Max
14. Independent human MAP kinase signal-transduction pathways defined by MEK and MKK isoforms
15. Mitochondria as the central control point of apoptosis
16. Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6
17. The molecular role of Myc in growth and transformation: Recent discoveries lead to new insights
18. N-myc and c-myc expression in Alzheimer disease, Huntington disease and Parkinson disease
19. Phosphorylated MAP kinase (ERK1, ERK2) expression is associated with early tau deposition in neurones and glial cells, but not with increased nuclear DNA vulnerability and cell death, in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration
20. Neurotoxicity of β-amyloid and prion peptides
21. Transactivation of gen expression by Myc is inhibited by mutation at the phosphorylation sites Thr-58 and Ser-62
22. Determination of the c-Myc DNA-binding site
23. Phosphorylation sites mapping in the N-terminal domain of c-Myc modulate its transforming potential
24. Proteins of the Myc network: Essential regulators of cell growth and differentiation
25. The proto-oncogene c-myc and apoptosis
26. Signal transduction by the c-Jun-N-terminal kinase (JNK): From inflammation to development
27. Presenilin overexpression arrests cells in the G1 phase of the cell cycle. Arrest potentiated by the Alzheimer's disease PS2 (N1411) mutant
28. Mechanisms of cell death in neurodegenerative disorders
29. Identification of a dual specificity kinase that activates the Jun kinase and p38-Mpk2
30. Overexpression of c-Myc and cell immortalization alters c-Myc phosphorylation
31. Hippocampal Myc and p53 expression following transient global ischemia
32. Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease
33. Re-entry into the cell cycle: A mechanism for neurodegeneration in Alzheimer disease
34. Signal transduction abnormalities in Alzheimer's disease: Evidence of pathogenic stimuli
35. Mechanisms underlying neural cell death in neurodegenerative diseases: Alterations of a developmentally-mediated cellular rheostat
36. JNK and p38 stress kinases-degenerative effectors of signal-transduction-cascades in the nervous system
37. Regulation and function of the JNK subgroup of MAP kinases
38. Neurons may live for decades with neurofibrillary tangles
39. Myc family oncoproteins function through a common pathway to transform normal cells in culture: Cross-interference by Max and trans-acting dominant mutants
40. Cell cycle markers in the hippocampus in Alzheimer's disease
41. The cell division cycle and the pathophysiology of Alzheimer's disease
42. Expression of cell division markers in the hippocampus in Alzheimer's disease and other neurodegenerative conditions
43. Upregulation of c-myc gene expression following focal ischemia in the rat brain
44. Myc oncogenes and human neoplastic disease
45. Caspases: Killer proteases
46. Regulation of c-Myc through phosphorylation at Ser-62 and Ser-71 by c-Jun N-terminal kinases
47. Mysterious liaisons: The relationship between c-Myc and the cell cycle
48. The role of caspases during apoptosis
49. Identification of the regulatory phosphorylation sites in pp42/mitogen-activated protein kinase (MAP kinase)
50. Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation
51. Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis
52. Mechanisms of apoptosis by C-Myc
53. A new bind for Myc
54. Cyclin' toward dementia: Cell cycle abnormalities and abortive oncogenesis in Alzheimer disease
55. Pro-inflammatory cytokines and environmental stress causes p38 MAP kinase activation by dual phosphorylation on tyrosyne and threonine
56. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway
57. Mitogen-activated protein kinase pathways
58. The role of c-myc in cellular growth control
59. Ras enhances Myc protein stability
60. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways
61. Targeted disruption of the MKK4 gene causes embryonic death, inhibition of c-Jun NH2-terminal kinase activation, and defects in AP-1 transcriptional activity
62. Apoptosis in the nervous system
63. Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease